Active Biotech AB (publ) (LON:0GQU)
London
· Delayed Price · Currency is GBP · Price in SEK 0.0942
+0.0085 (9.92%)
At close: May 8, 2025
Active Biotech AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 26.2 | 27.4 | 36.22 | 41.8 | 53.13 | 26.21 | Upgrade
|
Cash & Short-Term Investments | 26.2 | 27.4 | 36.22 | 41.8 | 53.13 | 26.21 | Upgrade
|
Cash Growth | 3.15% | -24.36% | -13.35% | -21.34% | 102.70% | -56.08% | Upgrade
|
Accounts Receivable | 3.5 | - | - | - | - | 0.28 | Upgrade
|
Other Receivables | - | 9.5 | 1.26 | 0.95 | 1.19 | 1.23 | Upgrade
|
Receivables | 3.5 | 9.5 | 1.26 | 0.95 | 1.19 | 1.51 | Upgrade
|
Prepaid Expenses | - | 2.32 | 1.24 | 1.38 | 1.53 | 1.5 | Upgrade
|
Other Current Assets | -0.1 | - | - | - | - | 1.06 | Upgrade
|
Total Current Assets | 29.6 | 39.21 | 38.71 | 44.12 | 55.86 | 30.28 | Upgrade
|
Property, Plant & Equipment | 3 | 3.35 | 4.72 | 6.26 | 0.95 | 1.87 | Upgrade
|
Other Intangible Assets | 0.2 | 0.25 | 0.25 | 0.25 | - | - | Upgrade
|
Other Long-Term Assets | 0.4 | 0.38 | 0.38 | 0.38 | 0 | 0 | Upgrade
|
Total Assets | 33.2 | 43.18 | 44.05 | 51.01 | 56.8 | 32.16 | Upgrade
|
Accounts Payable | - | 1.45 | 3.17 | 3.53 | 2.76 | 2.85 | Upgrade
|
Accrued Expenses | - | 5.44 | 5.36 | 6.37 | 5.98 | 4.75 | Upgrade
|
Current Portion of Leases | - | 1.65 | 1.55 | 1.61 | 0.76 | 1.31 | Upgrade
|
Other Current Liabilities | 10.3 | 0.36 | 0.3 | 0.56 | 0.41 | 0.44 | Upgrade
|
Total Current Liabilities | 10.3 | 8.91 | 10.38 | 12.06 | 9.9 | 9.35 | Upgrade
|
Long-Term Leases | - | 1.53 | 3 | 4.43 | 0.23 | 0.69 | Upgrade
|
Total Liabilities | 11.5 | 10.44 | 13.38 | 16.49 | 10.13 | 10.04 | Upgrade
|
Common Stock | 21.7 | 6.35 | 1.87 | 1.37 | 1.13 | 0.75 | Upgrade
|
Additional Paid-In Capital | - | 3,509 | 3,472 | 3,431 | 3,386 | 3,312 | Upgrade
|
Retained Earnings | - | -3,483 | -3,443 | -3,398 | -3,340 | -3,291 | Upgrade
|
Shareholders' Equity | 21.7 | 32.74 | 30.67 | 34.51 | 46.67 | 22.11 | Upgrade
|
Total Liabilities & Equity | 33.2 | 43.18 | 44.05 | 51.01 | 56.8 | 32.16 | Upgrade
|
Total Debt | - | 3.18 | 4.55 | 6.04 | 0.99 | 2 | Upgrade
|
Net Cash (Debt) | 26.2 | 24.21 | 31.67 | 35.76 | 52.15 | 24.21 | Upgrade
|
Net Cash Growth | 14.91% | -23.56% | -11.42% | -31.43% | 115.38% | -57.09% | Upgrade
|
Net Cash Per Share | 0.04 | 0.06 | 0.12 | 0.15 | 0.24 | 0.14 | Upgrade
|
Filing Date Shares Outstanding | 1,100 | 1,230 | 361.74 | 264.89 | 217.97 | 217.97 | Upgrade
|
Total Common Shares Outstanding | 1,100 | 1,066 | 361.74 | 264.89 | 217.97 | 145.24 | Upgrade
|
Working Capital | 19.3 | 30.3 | 28.33 | 32.06 | 45.95 | 20.93 | Upgrade
|
Book Value Per Share | 0.02 | 0.03 | 0.08 | 0.13 | 0.21 | 0.15 | Upgrade
|
Tangible Book Value | 21.5 | 32.5 | 30.42 | 34.27 | 46.67 | 22.11 | Upgrade
|
Tangible Book Value Per Share | 0.02 | 0.03 | 0.08 | 0.13 | 0.21 | 0.15 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.